QCG
DCPH

Quadrant Capital Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Quadrant Capital Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,965
Closed -$30.9K – 2787
2024
Q1 		$30.9K Hold
1,965
– – ﹤0.01% 1655
2023
Q4 		$31.7K Buy
1,965
+40
+2% +$510 ﹤0.01% 1610
2023
Q3 		$24.5K Hold
1,925
– – ﹤0.01% 1609
2023
Q2 		$27.1K Hold
1,925
– – ﹤0.01% 1566
2023
Q1 		$29.7K Hold
1,925
– – ﹤0.01% 1498
2022
Q4 		$31.6K Sell
1,925
-210
-10% -$3.42K ﹤0.01% 1430
2022
Q3 		$39K Buy
2,135
+159
+8% +$2.5K 0.01% 1184
2022
Q2 		$26K Buy
1,976
+39
+2% +$430 ﹤0.01% 1181
2022
Q1 		$18K Sell
1,937
-1,915
-50% -$16.3K ﹤0.01% 1394
2021
Q4 		$38K Buy
3,852
+3,823
+13,183% +$71.9K ﹤0.01% 1032
2021
Q3 		$1K Buy
+29
New +$926 ﹤0.01% 2430

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Quadrant Capital Group's DCPH Position: Q2 2024 in Review

Quadrant Capital Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 1,965 shares — an estimated $30.9K sold.

Quadrant Capital Group first reported a position in DCPH in Q3 2021 and held it in 11 quarters. The position peaked at $39K in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Quadrant Capital Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Quadrant Capital Group sold 1,965 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $30.9K.
  • Quadrant Capital Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Quadrant Capital Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $39K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Quadrant Capital Group's 13F filing for Q2 2024, filed 12 Aug 2024.